Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
J Cell Sci 134(8):jcs253880 Kummer D, Ebnet K (2018) Junctional adhesion molecules (JAMs): the JAM-integrin connection
August 2025: Viking Therapeutics announced positive topline Phase II VENTURE-Oral results for VK2735 tablet, a once-daily oral dual GLP-1/GIP receptor agonist, with up to 12.2% mean weight loss after 13 weeks
Liposomal encapsulation not only protects glutathione through digestion but also delivers it where absorption is higher
PlexusDx Precision Peptide Genetic Test examines variants in GIPR and FTO, and MC4R genes that directly influence appetite regulation and medication response
Guggulsterone phytosomes: A novel approach to alleviate hyperlipidemia in high-fat diet-fed rats
If you have documentation of prior GLP-1 use, your Maximus provider will help determine the most appropriate dose for your treatment plan
